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677JACC Vol. 51, No. 6, 2008 Correspondence
February 12, 2008:674–7f CRT upon improving left-sided filling pressures and cardiac
emodynamics, which, after all, should be the mechanism by
hich pulmonary congestion, dyspnea on exertion, and fatigue are
lleviated by CRT.
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eply
rs. Adelstein and Saba raise a number of criticisms regarding our
ecent publication in which we observed that the number of atrial
achyarrhythmia (AT) events in heart failure patients diminished
fter conventional dual-chamber pacemakers or defibrillators were
upgraded” to cardiac resynchronization (CRT) systems (1). We
ave endeavored to address their comments.
First, Drs. Adelstein and Saba indicate disappointment in our
ot citing their publication (2). This omission was not intentional;
ur manuscript was accepted on April 24, 2007, and was at the
ublishers when theirs was printed (July 15, 2007). Thus, publi-
ation schedules crossed. Second, they criticize how we counted
T events (i.e., mode switch counts with electrogram review when
vailable) without having documentation of all events (a limitation
oted by us). They are concerned that transient undersensing may
esult in our having counted “multiple” apparent individual AT
pisodes (instead of 1 ongoing episode), thereby overestimating
T frequency; further, they suggest that, absent electrograms, we
ould not substantiate that ATs were present. With regard to the
ormer, we believe that the device algorithms used and our
easurement techniques minimized the “overcounting” problem.
owever, if, as they contend, it was impossible to eliminate all
overcounting,” our “upgrade study model,” with each patient
eing his/her own control, inherently protected against an impor-
ant counting bias; error susceptibility would be similar before and
fter CRT upgrade. In this regard, our study design is more robust
han their case-control methodology (2). With regard to the
econd aspect of their documentation criticism, one might be led to
ssume that in their report Drs. Adelstein and Saba either vetted
very mode switch event with electrograms or censored those thatould not be vetted. However, neither seems to be true. In fact,
lthough they indicate that “electrographic data” were available in
8% of patients, they do not state unequivocally that all events
ere documented by electrograms. The probability of complete
etting is unlikely unless either data downloads were very frequent
r undocumented events were censored (which could result in
ndercounting). In fact, they admit that absent electrocardio-
raphic data “. . . episode counters and mode switch dura-
ions . . . were assumed to be correct.” In effect, their study is
ubject to the same criticism they level at us, while lacking the
nternal controls offered by our study design. Third, Drs. Adelstein
nd Saba criticized our focusing on AT events and AT rate as
linical end points, believing that AT burden is more important. In
his regard, we believe that episode duration is an important
eterminant of thromboembolic risk, but otherwise our opinions
re similar (3). Indeed, whereas the number of AT events and
urations that we provided may not be a precise “burden” measure,
hey provide a “burden” surrogate. Finally, the Pittsburgh research-
rs point out that, unlike both Fung et al. (4) and our study (1),
hey did not observe a significant CRT benefit. However, that may
ave been due to limitations of their study design. In fact, their
gures suggest that CRT patients did better than control patients;
pecifically, CRT was associated with a trend toward greater
T-free proportion at any given time. Potentially, had their
opulation been larger, or had they used a more robust study
odel (such as our “upgrade” approach), the trend toward benefit
ay have been significant.
Differences aside, we appreciate the interest shown by Drs.
delstein and Saba in our study and look forward to their
ontinuing to contribute to the better understanding of CRT in
linical care.
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